Abstract
Conclusion
In man, as has been demonstrated in animals, synthetic vitamin K administered in relatively large amounts has been found to counteract or neutralize the hypoprothrombinemia induced by a smallest single effectual dose of Dicumarol.
Get full access to this article
View all access options for this article.